Evommune EVMN
NYSE EVMN
$5.18 -0.20 (-3.72%)
As of: Oct 21, 2026 · 3:59 PM EDT

Evommune (EVMN) EPS (Diluted) (2024 - 2026)

Updated

Evommune's EPS (Diluted) came in at -$0.89 for Q2 2026, compared with -$8.80 a year earlier.

Analysis

Evommune (EVMN) EPS (Diluted) (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Evommune reported EPS (Diluted) of -$2.62; for FY2025, it came in at -$11.22.

  • Going back by year, EPS (Diluted) was -$44.29 in FY2024.
  • The five-year range for quarterly EPS (Diluted) is -$13.74 (Q4 2024) to -$0.64 (Q1 2026).
  • Business Quant data shows EVMN's EPS (Diluted) at -$0.64 (Q1 2026), -$4.61 (Q4 2025) and -$8.07 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.94
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 2.27
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.04
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -0.54
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.67
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.60
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 4.37
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -8.44
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -0.04
10 Evommune 186.46 Mn -451.06 Mn - -0.89
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.89
Mar 31, 2026 -0.64
Dec 31, 2025 -4.61
Sep 30, 2025 -8.07
Jun 30, 2025 -8.80
Mar 31, 2025 -9.48
Dec 31, 2024 -13.74
Sep 30, 2024 -10.47
API Access

Evommune EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=EVMN&period=max&api_key=YOUR_API_KEY